Economic burden of patients with anemia in selected diseases

Value in Health

Volumn 8, Issue 6, 2005, Pages 629-638

  Ershler, William B ^a   Chen, Kristina ^b   Reyes, Eileen B ^b   Dubois, Robert ^b  

^a Institute for Advanced Studies in Aging and Geriatric Medicine   (United States)

^b Cerner Health Insights   (United States)

Author keywords

Anemia; Comorbid conditions; Economics; Indirect costs

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE RECEPTOR; AMIGESIC; AMINOSALICYLIC ACID; ANACIN; ANAFLEX 750; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIINFECTIVE AGENT; ARTHROTEC; ASCRIPTIN; BAYER; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CELECOXIB; CHOLINE; CHOLINE MAGNESIUM TRISALICYLATE; CMT; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; CYCLOSPORIN A; DICLOFENAC; DIGITALIS GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETANERCEPT; EXCEDRIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LEFLUNOMIDE; LOOP DIURETIC AGENT; MARTHRITIC; MESALAZINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; ROFECOXIB; SALICYLATE SODIUM; SALICYLIC ACID; SALSALATE; STEROID; TRICOSAL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALDECOXIB; VASODILATOR AGENT;

ADULT; AGED; ANEMIA; ARTICLE; CHEMOTHERAPY; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENTERITIS; HEALTH CARE COST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS;

EID: 30944445958     PISSN: 10983015     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2005.00058.x     Document Type: Article

References (21)

1. Adams PF, Hendershot GE, Marano MA. Current estimates from the National Health Interview Survey, 1996. National Center for Health Statistics. Vital Health Stat 1999;10:1-203. WWW document: Available from: http://www.cdc.gov/ nchs/ data/series/sr_10/sr10_200.pdf [Accessed June 21, 2004].
2. Dallman PR, Yi PR, Johnson C. Prevalence and causes of anemia in the United States, 1976 to 1980. Am J Clin Nutr 1984;39:437-45.
3. Kausz AT, Steinberg EP, Nissenson AR, Pereira BJG. Prevalence and management of anemia among patients with chronic kidney disease in a health maintenance organization. Dis Manag Health Outcomes 2002;10:505-13.
4. Baer AN, Dessypris EN, Krantz SB. The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis. Semin Arthritis Rheum 1990;19:209-33.
5. Knight K, Wade S, Balducci L. Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med 2004;116(Suppl. 7A):S11-26.
6. Belperio PS, Rhew DC. Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med 2004;116(Suppl. 7A):S27-43.
7. Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med 2004;116(Suppl. 7A):S44-9.
8. Wilson AYuH, Goodnough LT, Nissenson AR. Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. Am J Med 2004;116(Suppl. 7A):S50-7.
9. US Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health, 2nd edn. Washington, DC: US Government Printing Office, 2000.
10. Littlewood TJ. The impact of hemoglobin levels on treatment outcomes in patients with cancer. Semin Oncol 2001;28 (Suppl. 8):S49-53.
11. Gasche C. Anemia in IBD: the overlooked villain. Inflamm Bowel Dis 2000;6:142-50.
12. Bureau of Labor Statistics Home Page. WWW document: Available from: http://www.bls.gov [Accessed November 15, 2003].
13. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9CM administrative databases. J Clin Epidemiol 1992; 45:613-19.
14. Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. WWW document: Available from: http://www.cdc.gov/ nchswww/nchshome.htm [Accessed June 6, 2004].
15. Ludwig H, Van Belle SV, Barrett-Lee P, et al. The European Cancer Anemia Survey (EGAS): a large multinational, prospective survey defining the prevalence, incidence, and treatment of anemia in cancer patients. Eur J Cancer 2004;40:2293-306.
16. McClellan W, Aronoff SL, Bolton WK, et al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin 2004;20:1501-10.
17. Felker GM, Adams KF Jr, Gattis WA, O'Connor CM. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol 2004;44:959-66.
18. Witte KK, Desilva R, Chattopadhyay S, et al. Are hematinic deficiencies the cause of anemia in chronic heart failure? Am Heart J 2004;147:924-30.
19. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure. Circulation 2003;107:223-5.
20. Crosato M, Steinborn W, Anker SD. Anemia in chronic congestive heart failure: frequency, prognosis, and treatment. Heart Fail Monit 2003;4:2-6.
21. Goodnough LT, Nissenson AR. Anemia and its clinical consequences in patients with chronic diseases. Am J Med 2004;116(Suppl. 7A):S1-2 (Tables).